Research Papers

25 of 121 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
RNA Silencing in the Management of Dyslipidemias.
Henney NC; Banach M; Penson PE.
Curr Atheroscler Rep (Unknown)
Published: 2021
1/6 Transparent
Phytosterols and Cardiovascular Disease.
Makhmudova U; Schulze PC; Lütjohann D; Weingärtner O.
Curr Atheroscler Rep (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (…
D'Erasmo L; Bini S; Arca M.
Curr Atheroscler Rep (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Ambient Air Pollution and Atherosclerosis: Recent Updates.
Bevan GH; Al-Kindi SG; Brook R; Rajagopalan S.
Curr Atheroscler Rep (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Managing Ischemic Heart Disease in Women: Role of a Women's Heart Center.
Khandelwal A; Bakir M; Bezaire M; Costello B; Gomez JMD; Hoover V; Nazir NT; Nichols K; Reisenberg A; Rao A; Sanghani R; Tracy M; Volgman AS.
Curr Atheroscler Rep (Unknown)
Published: 2021
1/6 Transparent
Takotsubo Syndrome: Uncovering Myths and Misconceptions.
Cammann VL; Würdinger M; Ghadri JR; Templin C.
Curr Atheroscler Rep (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Behavioral Medicine for Sedentary Behavior, Daily Physical Activity, and Exercise to Prevent Cardiovascular Disease: A …
Hannan M; Kringle E; Hwang CL; Laddu D.
Curr Atheroscler Rep (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updat…
Jain V; Al Rifai M; Mahtta D; Liu J; Hussain A; Virani SS.
Curr Atheroscler Rep (Unknown)
Published: 2021
1/6 Transparent
The Genetic Basis of Hypertriglyceridemia.
Carrasquilla GD; Christiansen MR; Kilpeläinen TO.
Curr Atheroscler Rep (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Novel RNAi-Based Therapies for Atherosclerosis.
Ruotsalainen AK; Mäkinen P; Ylä-Herttuala S.
Curr Atheroscler Rep (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
COVID and Cardiovascular Disease: What We Know in 2021.
Chilazi M; Duffy EY; Thakkar A; Michos ED.
Curr Atheroscler Rep (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies.
Banach M; Penson PE.
Curr Atheroscler Rep (Unknown)
Published: 2021
2/6 Transparent
Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents.
Cohen H; Stefanutti C; The Mighty Medic Satellite Research Group for Pediatric Dyslipidemia.
Curr Atheroscler Rep (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Food Insecurity and Cardiovascular Disease Risk.
Liu Y; Eicher-Miller HA.
Curr Atheroscler Rep (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
High-Density Lipoproteins and Serum Amyloid A (SAA).
Webb NR.
Curr Atheroscler Rep (Unknown)
Published: 2021
1/6 Transparent
High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis.
Rodriguez A.
Curr Atheroscler Rep (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Highlights from Studies Presented at the American Heart Association Scientific Session 2020: Navigating New Roads in Pr…
Hussain A; Al Rifai M; Mahtta D; Liu J; Jain V; Virani SS.
Curr Atheroscler Rep (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibra…
Fruchart JC; Hermans MP; Fruchart-Najib J; Kodama T.
Curr Atheroscler Rep (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia.
Pang J; Chan DC; Watts GF.
Curr Atheroscler Rep (Unknown)
Published: 2020
1/6 Transparent
Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analy…
Baral R; White M; Vassiliou VS.
Curr Atheroscler Rep (Unknown)
Published: 2020
1/6 Transparent
The Long Non-coding Road to Atherosclerosis.
Josefs T; Boon RA.
Curr Atheroscler Rep (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.
Moriarty PM; Gorby LK; Stroes ES; Kastelein JP; Davidson M; Tsimikas S.
Curr Atheroscler Rep (Unknown)
Published: 2020
1/6 Transparent
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual C…
Fruchart JC; Hermans MP; Fruchart-Najib J.
Curr Atheroscler Rep (Unknown)
Published: 2020
1/6 Transparent
Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic.
Giordano A; Biondi-Zoccai G; Frati G; Bartorelli AL.
Curr Atheroscler Rep (Unknown)
Published: 2020
1/6 Transparent
A Review of the Relationship Between CTRP Family and Coronary Artery Disease.
Si Y; Fan W; Sun L.
Curr Atheroscler Rep (Unknown)
Published: 2020
2/6 Transparent
Funding Declared